AI Science Tracker
EN

Harbin Medical University

4 discoveries from 2020 to 2024

Discoveries

Three selected expression candidates agree in an osteoarthritis cell comparison

Source check: Source checked. Not independent scientific confirmation.

Finding: A multi-algorithm expression screen nominated four osteoarthritis candidates. In the source’s subsequent cell comparison, MAP3K8 was higher and AGMAT and PER1 were lower, while XIST showed no significant difference. This limited assay result does not establish diagnostic performance, a causal disease role or treatment benefit.

Technology: LASSO; random forest; bagged trees; Bayesian classifier; Boruta; learning vector quantization

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Six fitted feature-selection/classification methods nominated genes selected by at least five approaches, determining the four candidates checked in the later assay.
Test and result
The computational screen used GSE12021 and GSE55235. The source’s original assay Results and Figure8 report three concordant candidate-expression directions and one nonsignificant comparison.
Limitation / still unknown
The original GSE12021 counts are arrays, not unique people: its 20 osteoarthritis arrays represent 10 patients across paired platforms, and 13 control arrays represent nine people. The single-cell series comprises three osteoarthritis donors with relatively intact and damaged tissues, not independent healthy donors. Synovial screening and the later cartilage-cell comparison concern different contexts. Experimental replication details and procedures were not independently inspected; the result is not clinical or separate-team validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11402953/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary computational selection Methods and high-level measured Results/Figure8; primary GEO metadata; no operational laboratory procedures reviewed.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 1/5 · Validation 3/5 · Novelty 1/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Random-forest screening identifies a breast-cancer growth-suppressing role for PCAT19

Source check: Source checked. Not independent scientific confirmation.

Finding: A random-forest survival model helped prioritize lncRNAs from 1054 breast-cancer expression profiles; overlap with differential expression and a separate expression database nominated PCAT19. Knocking down PCAT19 increased proliferation in two breast-cancer cell lines, while overexpression reduced xenograft growth in mice. The work supports a preclinical growth-suppressing role, not a validated treatment. Predicted regulatory networks remain hypotheses, and inconsistent clinical-prognosis wording is not used to establish patient benefit.

Technology: Random forest survival model

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Random-forest survival feature importance selected the top 10% of lncRNAs from 1054 TCGA breast-cancer profiles; intersection with differential expression and external expression evidence helped select PCAT19 for functional experiments.
Test and result
Random-forest prioritization was followed by PCAT19 knockdown in two breast-cancer cell lines and overexpression in a mouse xenograft model, supporting an effect on growth. Migration and invasion changes were not statistically significant.
Limitation / still unknown
No clinical intervention or treatment benefit is established. The paper contains inconsistent directions in its clinical-prognosis narrative and reports 151 versus 153 tissue cases in different sections; these clinical claims are not represented as validated findings. The proposed ceRNA network remains computational.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1002/cam4.5872 · https://pmc.ncbi.nlm.nih.gov/articles/PMC10242319/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Exact article-front DOI/title/PMCID and publication date; full primary Methods, Results and limitations. Admission represents the model-prioritized experimental growth result; contradictory clinical prognosis descriptions are explicitly excluded from the claim..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Roles of Anxiety and Depression in Predicting Cardiovascular Disease Among Patients With Type 2 Diabetes Mellitus: A Machine Learning Approach.

Source check: Source checked. Not independent scientific confirmation.

Finding: Anxiety and depression features predict cardiovascular risk in a validated dataset. Organization is unavailable in the deposited bibliographic metadata.

Technology: Deep neural network for cardiovascular-risk prediction

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A deep neural network predicted cardiovascular risk from biopsychosocial data in patients with type 2 diabetes.
Test and result
Anxiety and depression features predict cardiovascular risk in a validated dataset.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8113686/

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Learned ultrasound features classify breast sentinel-node involvement

Source check: Source checked. Not independent scientific confirmation.

Finding: Image-pretrained convolutional models were fine-tuned on breast ultrasound images and combined with axillary ultrasound findings. In a retrospective second-hospital test of 395 women, the combined model classified pathology-referenced sentinel-node involvement with an AUC of 0.848. Avoided surgery was hypothetical, not an observed clinical benefit.

Technology: ImageNet-pretrained convolutional neural networks with ultrasound fine-tuning

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Convolutional networks pre-trained on 1.28 million ImageNet images learned ultrasound features through fine-tuning; their predicted probabilities enabled the node-involvement evaluation.
Test and result
937 patients from two hospitals: 542 for development and 395 for testing; 3,049 images. The reference was surgical lymph-node assessment. Radial and anti-radial image-model probabilities were fused.
Limitation / still unknown
Retrospective exclusions and ultrasound-visible lesion selection limit transfer. Images were processed individually without explicitly modeling their correlation. The separate sequential non-sentinel-node analysis has conditional denominators and is not represented by the quoted AUC. Supplementary architecture and threshold-selection details were not independently inspected; no reduced surgery or outcome benefit was measured.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7519251/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Indexed primary clinical design, convolutional-model operation, reference evaluation and limitations; exact primary DOI/title/PMCID and fresh PubMed electronic date/notice metadata..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.